• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Oct27
HUADONG MEDICINE released FY2025 9 Months earnings on October 27 After-Market (BJT), actual revenue CNY 32.66 B, actual EPS CNY 1.5658
01:00
HUADONG MEDICINE released FY2025 Q3 earnings on October 27 After-Market (BJT), actual revenue CNY 10.99 B (forecast CNY 11.25 B), actual EPS CNY 0.5375 (forecast CNY 0.5323)
01:00
Oct20
HUADONG MEDICINE to Release FY2025 Q3 Earnings on October 28 After-Market (BJT), Forecast Revenue CNY 11.25 B, EPS CNY 0.5323
01:29
Aug19
HUADONG MEDICINE released FY2025 Semi-Annual Earnings on August 19 After-Market (BJT), actual revenue CNY 21.67 B, actual EPS CNY 1.0293
01:00
HUADONG MEDICINE released FY2025 Q2 earnings on August 19 After-Market (BJT), actual revenue CNY 10.94 B (forecast CNY 11.74 B), actual EPS CNY 0.507 (forecast CNY 0.5)
01:00
Aug14
Huadong Medicine Introduces Its Product Pipeline in Weight Loss and Diabetes Management
01:48

Schedules & Filings

Schedules
Filings
Oct27
Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 10.99 B, Net Income 933.09 M, EPS 0.5375

Sep18
Distribution Plan(CST)

Cash dividend 0.35 CNY

Distribution Plan(CST)

Cash dividend 0.35 CNY

View More

Stock List

Top Gainers
Top Decliners
Northbound Connect
Symbol
Price
%Chg
Change
View More